Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial

✍ Scribed by Cassidy, J; Douillard, J-Y; Twelves, C; McKendrick, J J; Scheithauer, W; Bustová, I; Johnston, P G; Lesniewski-Kmak, K; Jelic, S; Fountzilas, G

• Book ID: 109998779
• Publisher: Nature Publishing Group
• Year: 2006
• Tongue: English
• Weight: 137 KB
• Volume: 94
• Category: Article
• ISSN: 0007-0920
• DOI: 10.1038/sj.bjc.6603059